All Publications
Worob, A., & Wenthur, C. (2019). DARK Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice/K2).
ACS chemical neuroscience, 10.1021/acschemneuro.9b00586. Advance online publication.
https://doi.org/10.1021/acschemneuro.9b00586
Hwang, C. S., Smith, L. C., Wenthur, C. J., Ellis, B., Zhou, B., & Janda, K. D. (2019). Heroin vaccine: Using titer, affinity, and antinociception as metrics when examining sex and strain differences.
Vaccine,
37(30), 4155–4163.
https://doi.org/10.1016/j.vaccine.2019.05.061
Wenthur, C. J., Gautam, R., Zhou, B., Vendruscolo, L. F., Leggio, L., & Janda, K. D. (2019). Ghrelin Receptor Influence on Cocaine Reward is Not Directly Dependent on Peripheral Acyl-Ghrelin.
Scientific reports,
9(1), 1841.
https://doi.org/10.1038/s41598-019-38549-z
Hwang, C. S., Bremer, P. T., Wenthur, C. J., Ho, S. O., Chiang, S., Ellis, B., Zhou, B., Fujii, G., & Janda, K. D. (2018). Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality.
Molecular pharmaceutics,
15(3), 1062–1072.
https://doi.org/10.1021/acs.molpharmaceut.7b00933
Wenthur, C. J., Zhou, B., & Janda, K. D. (2017). Vaccine-driven pharmacodynamic dissection and mitigation of fenethylline psychoactivity.
Nature,
548(7668), 476–479.
https://doi.org/10.1038/nature23464
Wenthur, C. J., Cai, X., Ellis, B. A., & Janda, K. D. (2017). Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
Bioorganic & medicinal chemistry letters,
27(16), 3666–3668.
https://doi.org/10.1016/j.bmcl.2017.07.014
Gooyit, M., Miranda, P. O., Wenthur, C. J., Ducime, A., & Janda, K. D. (2017). Influencing Antibody-Mediated Attenuation of Methamphetamine CNS Distribution through Vaccine Linker Design.
ACS chemical neuroscience,
8(3), 468–472.
https://doi.org/10.1021/acschemneuro.6b00389
Kimishima, A., Wenthur, C. J., Zhou, B., & Janda, K. D. (2017). An Advance in Prescription Opioid Vaccines: Overdose Mortality Reduction and Extraordinary Alteration of Drug Half-Life.
ACS chemical biology,
12(1), 36–40.
https://doi.org/10.1021/acschembio.6b00977
Kimishima, A., Wenthur, C. J., Eubanks, L. M., Sato, S., & Janda, K. D. (2016). Cocaine Vaccine Development: Evaluation of Carrier and Adjuvant Combinations That Activate Multiple Toll-Like Receptors.
Molecular pharmaceutics,
13(11), 3884–3890.
https://doi.org/10.1021/acs.molpharmaceut.6b00682
